4D Molecular Therapeutics, Inc. (FDMT) Total liabilities 2019–2025
4D Molecular Therapeutics, Inc. (FDMT) total liabilities at each fiscal year-end, per SEC filings.
$61.0MFY2025 · since FY2019: $28.2M → $61.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $61.0M | +22.6% |
| FY2024 | $49.8M | +55.3% |
| FY2023 | $32.1M | +5.1% |
| FY2022 | $30.5M | -11.3% |
| FY2021 | $34.4M | +7.6% |
| FY2020 | $31.9M | +13.2% |
| FY2019 | $28.2M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice